WallStSmart

Cabot Corporation (CBT)vsEcolab Inc (ECL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ecolab Inc generates 346% more annual revenue ($16.08B vs $3.61B). ECL leads profitability with a 12.9% profit margin vs 8.6%. CBT appears more attractively valued with a PEG of 1.00. CBT earns a higher WallStSmart Score of 57/100 (C).

CBT

Buy

57

out of 100

Grade: C

Growth: 2.0Profit: 7.5Value: 7.3Quality: 7.5
Piotroski: 4/9Altman Z: 2.87

ECL

Buy

55

out of 100

Grade: C-

Growth: 6.0Profit: 6.5Value: 4.7Quality: 5.8
Piotroski: 3/9Altman Z: 2.30
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CBTSignificantly Overvalued (-95.2%)

Margin of Safety

-95.2%

Fair Value

$38.90

Current Price

$72.74

$33.84 premium

UndervaluedFair: $38.90Overvalued
ECLSignificantly Overvalued (-142.8%)

Margin of Safety

-142.8%

Fair Value

$125.04

Current Price

$268.54

$143.50 premium

UndervaluedFair: $125.04Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CBT4 strengths · Avg: 8.3/10
Return on EquityProfitability
21.8%9/10

Every $100 of equity generates 22 in profit

PEG RatioValuation
1.008/10

Growing faster than its price suggests

P/E RatioValuation
12.4x8/10

Attractively priced relative to earnings

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

ECL3 strengths · Avg: 8.7/10
Market CapQuality
$74.91B9/10

Large-cap with strong market position

Return on EquityProfitability
22.5%9/10

Every $100 of equity generates 23 in profit

Revenue GrowthGrowth
17.8%8/10

17.8% revenue growth

Areas to Watch

CBT2 concerns · Avg: 2.0/10
Revenue GrowthGrowth
-11.1%2/10

Revenue declined 11.1%

EPS GrowthGrowth
-18.2%2/10

Earnings declined 18.2%

ECL4 concerns · Avg: 3.3/10
P/E RatioValuation
36.4x4/10

Premium valuation, high expectations priced in

Price/BookValuation
11.4x4/10

Trading at 11.4x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
2.732/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CBT

The strongest argument for CBT centers on Return on Equity, PEG Ratio, P/E Ratio. PEG of 1.00 suggests the stock is reasonably priced for its growth.

Bull Case : ECL

The strongest argument for ECL centers on Market Cap, Return on Equity, Revenue Growth. Revenue growth of 17.8% demonstrates continued momentum.

Bear Case : CBT

The primary concerns for CBT are Revenue Growth, EPS Growth.

Bear Case : ECL

The primary concerns for ECL are P/E Ratio, Price/Book, Piotroski F-Score.

Key Dynamics to Monitor

CBT profiles as a value stock while ECL is a growth play — different risk/reward profiles.

ECL carries more volatility with a beta of 0.98 — expect wider price swings.

ECL is growing revenue faster at 17.8% — sustainability is the question.

ECL generates stronger free cash flow (758M), providing more financial flexibility.

Bottom Line

CBT scores higher overall (57/100 vs 55/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cabot Corporation

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Cabot Corporation (CBT) is a premier global specialty chemicals and performance materials company, recognized for its innovative solutions that elevate performance, sustainability, and safety in diverse applications across industries such as tire, plastics, coatings, and electronics. The company specializes in carbon black, recovery solutions, and specialty compounds, underpinned by strong research and development capabilities that foster continuous innovation. With a commitment to operational excellence and environmental sustainability, Cabot Corporation seeks to minimize its ecological footprint while maximizing performance outcomes, reinforcing its status as a trusted partner in advanced materials and a leader in sustainable practices.

Visit Website →

Ecolab Inc

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Ecolab Inc., headquartered in St. Paul, Minnesota, is an American corporation that develops and offers services, technology and systems that specialize in water treatment, purification, cleaning and hygiene in a wide variety of applications. It helps organizations both private market as well as public treat their water, not only for drinking directly, but also for use in food, healthcare, hospitality related safety and industry.

Want to dig deeper into these stocks?